Items where Author is "Madrigal, JA"

DE LA PEÑA, H., MADRIGAL, J.A., RUSAKIEWICZ, S., BENCSIK, M., CAVE, G.W.V., ALI, S., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2009. Artificial exosomes as tools for basic and clinical immunology. Journal of Immunological Methods, 344 (2), pp. 121-132. ISSN 0022-1759

DE, L., MADRIGAL, J.A., BENESIK, M., CAVE, G.W.V., SELMAN, A., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2006. Artificial super para magnetic nano APC for active and adoptive immunotherapy. Blood, 108 (11). ISSN 0006-4971

DE, L., MADRIGAL, J.A., BENCSIK, M., CAVE, G.W.V., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2005. Hemato nanotechnology: artificial APC system for T cell adoptive and active immunotherapy. In: 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, USA, 10-13 December 2005, Atlanta, GA, USA.

DE, L., MADRIGAL, J.A., BENCSIK, M., CAVE, G.W.V., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2005. Hemato nanotechnology: artificial APC system for T cell adoptive and active immunotherapy. Blood, 106 (11), p. 3907. ISSN 0006-4971

MADRIGAL, J.A., TRAVERS, P.J. and DODI, I.A., 2005. Immunotherapeutic aspects of stem cell transplantation. Hematology, 10, pp. 289-292. ISSN 1024-5332

RUSAKIEWICZ, S., DODI, I.A., LOCONTO, J., TRAVERS, P.J. and MADRIGAL, J.A., 2004. Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells Molecules and Diseases, 33 (3), p. 191. ISSN 1079-9796

ROBERTS, C.H., ROBINSON, J., DODI, I.A., MADRIGAL, J.A. and MARSH, S.G.E., 2004. The European searchable tumour cell line database (ESTDAB). Genes and Immunity, 5. ISSN 1466-4879

ZAL, B., KASKI, J.C., ARNO, G., AKIYU, J.P., XU, Q.B., COLE, D., WHELAN, M., RUSSELL, N., MADRIGAL, J.A., DODI, I.A. and BABOONIAN, C., 2004. Heat-shock protein 60-reactive CD4(+)CD28(null) T cells in patients with acute coronary syndromes. Circulation, 109 (10), pp. 1230-1235. ISSN 0009-7322

CHEN, F.E., WEN, W.S., HUANG, G.W., TRAVERS, P., DODI, I.A. and MADRIGAL, J.A., 2004. High frequency CD4+CD25+ Treg cells in nasopharyngeal carcinoma is associated with suppression of CD8 T cell mediated response to latency II EBV antigens. Blood, 104 (11). ISSN 0006-4971

DODI, I.A., VAN, R., FORDE, H.C., ROURA-MIR, C., JARAQUEMADA, D., GOLDMAN, J.M. and MADRIGAL, J.A., 2002. CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect. Cytotherapy, 4 (4), pp. 353-363. ISSN 1465-3249

DODI, I.A., RUSAKIEWICZ, S., AUBERT, G., CLARKE, R., CHRISTMAS, S., CREASER, C., BONNER, P., REES, R., TRAVERS, P.J. and MADRIGAL, J.A., 2002. Definition of the breakpoint fusion peptides for HLA-A3 and HLA-B8 in CML cells. Tissue Antigens, 59, p. 45. ISSN 0001-2815

CHEN, F.E., AUBERT, G., TRAVERS, P., DODI, I.A. and MADRIGAL, J.A., 2002. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy, 4 (1), pp. 41-48. ISSN 1465-3249

DE, L., MADRIGAL, J.A., BENESIK, M., CAVE, G.W.V., SELMAN, A., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2001. Artificial super para magnetic nano APC for active and adoptive immunotherapy. In: Symposium of the International Society of Molecular Evolution, Guananacaste, Costa Rica, 8-12 January 2001, Guananacaste, Costa Rica.

AUBERT, G., HASSAN-WALKER, A.F., MADRIGAL, J.A., EMERY, V.C., MORTE, C., GRACE, S., KOH, M.B.C., POTTER, M., PRENTICE, H.G., DODI, I.A. and TRAVERS, P.J., 2001. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. Journal of Infectious Diseases, 184 (8), pp. 955-963. ISSN 0022-1899

CLARK, R.E., DODI, I.A., HILL, S.C., LILL, J.R., AUBERT, G., MACINTYRE, A.R., ROJAS, J., BOURDON, A., BONNER, P.L.R., WANG, L.H., CHRISTMAS, S.E., TRAVERS, P.J., CREASER, C.S., REES, R.C. and MADRIGAL, J.A., 2001. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood, 98 (10), pp. 2887-2893. ISSN 0006-4971

MORTE, C., DODI, I.A., MORGAN, C.L., PAY, A.L., TRAVERS, P.J. and MADRIGAL, J.A., 1999. Release of IFN gamma by NK and T-cells as a measure of the immune response to CMV infection in CMV-positive and CMV-negative individuals. Blood, 94 (10). ISSN 0006-4971

DODI, I.A., VAN, R., ROURA-MIR, C., FORDE, H., FISCHER, G., JARAQUEMADA, D., GOLDMAN, J.M. and MADRIGAL, J.A., 1998. Analysis of TCR V(beta) usage in T cell lines showing specificity for autologous leukaemic cells generated from a patient receiving DLT for relapse following BMT IA. Bone Marrow Transplantation, 21. ISSN 0268-3369

ARGUELLO, J.R., LITTLE, A.M., BOHAN, E., GALLARDO, D., O'SHEA, J., DODI, I.A., GOLDMAN, J.M. and MADRIGAL, J.A., 1998. A high resolution HLA class I and class II matching method for bone marrow donor selection. Bone Marrow Transplantation, 22 (6), pp. 527-534. ISSN 0268-3369

VANRHEE, F., DODI, I.A., FORDE, H., PEREZ, I., FISHER, G., GOLDMAN, J.M. and MADRIGAL, J.A., 1996. CD4 positive leukemia specific T cell clones are present during the graft-versus-leukemia response after allogeneic bone marrow transplantation for chronic myeloid leukemia. Human Immunology, 49, p. 38. ISSN 0198-8859

DODI, I.A., VANRHEE, F., FORDE, H., CRUZ, I.P., FISCHER, G., GOLDMAN, J.M. and MADRIGAL, J.A., 1996. Graft-versus-leukaemia (GVL) effect post allogeneic BMT is mediated by CML specific T cell clones. Human Immunology, 47, p. 463. ISSN 0198-8859

VANRHEE, F., DODI, I.A., FORDE, H., CRUZ, I.P., FISCHER, G., GOLDMAN, J.M. and MADRIGAL, J.A., 1996. Graft-versus-leukaemia effect (GVL) post allogeneic BMT is mediated by CML specific T cell clones. British Journal of Haematology, 93, p. 297. ISSN 0007-1048

KHAKOO, S.I., LING, R., HORTEGA, E., SCOTT, I., DODI, I.A., COHEN, S.B.A., LITTLE, A.M., HARRISON, T.J., MADRIGAL, J.A. and DUSHEIKO, G.M., 1996. The cytotoxic T lymphocyte (CTL) response in chronic hepatitis B infection. Use of an HLA class I matched dual transfectant model. Hepatology, 24 (4), p. 391. ISSN 0270-9139

DODI, I.A., VANRHEE, F., FORDE, H., GOLDMAN, J.M. and MADRIGAL, J.A., 1995. Examination of T cell clones derived from patients receiving DLT relapse following bone marrow transplantation. Blood, 86 (10), p. 2843. ISSN 0006-4971